Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Petra J. Woestenberg"'
Autor:
Petra J. Woestenberg, Audrey J. King, Johannes Berkhof, Hester E. de Melker, Joske Hoes, Christian J. P. A. Hoebe, Marianne A B van der Sande, Birgit H B van Benthem, Johannes A. Bogaards
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 72(5), E103-E111
Clinical Infectious Diseases, 72(5), E103-E111. Oxford University Press
Medical Microbiological Laboratories and Public Health Services 2021, ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ', Clinical Infectious Diseases, vol. 72, no. 5, pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770
Clinical Infectious Diseases, 72(5), E103-E111
Clinical Infectious Diseases, 72(5), E103-E111. Oxford University Press
Medical Microbiological Laboratories and Public Health Services 2021, ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ', Clinical Infectious Diseases, vol. 72, no. 5, pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770
Background Human papillomavirus (HPV) vaccination programs achieve substantial population-level impact, with effects extending beyond protection of vaccinated individuals. We assessed trends in HPV prevalence up to 8 years postvaccination among men a
Autor:
Pascal van der Weele, Audrey J. King, Johannes A. Bogaards, Petra J. Woestenberg, Birgit H B van Benthem
Publikováno v:
The Journal of Infectious Diseases
Journal of Infectious Diseases, 220(7), 1141-1146. Oxford University Press
Journal of Infectious Diseases, 220(7), 1141-1146. Oxford University Press
To substantiate cross-protection reported across AS04-adjuvanted bivalent human papillomavirus (HPV) vaccine (2vHPV) studies, we reevaluated vaccine effectiveness against type-specific HPV positivity as a function of phylogenetic distance to vaccine
Autor:
Fiona R. M. van der Klis, Audrey J. King, Suzan Leussink, Hella Pasmans, Birgit H B van Benthem, Petra J. Woestenberg, Johannes A. Bogaards, Christian J. P. A. Hoebe, Marianne A B van der Sande
Publikováno v:
Vaccine, 38(17), 3321-3329. Elsevier BV
Vaccine, 38(17), 3321-3329. ELSEVIER SCI LTD
Woestenberg, P J, van Benthem, B H B, Bogaards, J A, King, A J, van der Klis, F R M, Pasmans, H, Leussink, S, van der Sande, M A B & Hoebe, C J P A 2020, ' HPV infections among young MSM visiting sexual health centers in the Netherlands : Opportunities for targeted HPV vaccination ', Vaccine, vol. 38, no. 17, pp. 3321-3329 . https://doi.org/10.1016/j.vaccine.2020.03.002
Vaccine, 38(17), 3321-3329. ELSEVIER SCI LTD
Woestenberg, P J, van Benthem, B H B, Bogaards, J A, King, A J, van der Klis, F R M, Pasmans, H, Leussink, S, van der Sande, M A B & Hoebe, C J P A 2020, ' HPV infections among young MSM visiting sexual health centers in the Netherlands : Opportunities for targeted HPV vaccination ', Vaccine, vol. 38, no. 17, pp. 3321-3329 . https://doi.org/10.1016/j.vaccine.2020.03.002
Introduction: In 2009, girls-only HPV16/18 vaccination was introduced in the Netherlands which has achieved 46-61% uptake. Heterosexual men have benefitted from herd protection, but it is unknown whether men who have sex with men (MSM) also benefit f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fead32d96195767da50afa9631b4adb3
https://research.vumc.nl/en/publications/84416eeb-f1a1-430c-a18a-3ddb890f8aef
https://research.vumc.nl/en/publications/84416eeb-f1a1-430c-a18a-3ddb890f8aef
Autor:
J. Weel, P. Oostvogel, I. Molenaar, Audrey J. King, J. Schirm, E. Doorn, Petra F. G. Wolffs, Christian J. P. A. Hoebe, M. van de Pas, I. de Koning, J. Janssen, A. Gelissen-Hansen, M. Illidge-Onder de Linden, P. Sanders, M. Hooghiemstra, J. Kiewiet, Han S. A. Fennema, C. de Mooij, P. Hut-van Vliet, S. Lakbiach, Dirk S. Luijt, M. Pelsers, F. De Groot, T. van Zwet, M. Wolfhagen, H. Huisman, C. van Ruitenbeek, L. Masthoff, C. Touwen, H. Verbakel, Antoinette A. T. P. Brink, M. Schutten, K. Adams, I. Hondelink, N. Duijvendijk, R. Tiemessen, A.G.M. Buiting, Arjan Hogewoning, Robine Donken, Antoine M Beerens, T. de Haas, F. Postma, M. de Graas, F. Verduyn-Lunel, Jaco J. Verweij, Peter M. Schneeberger, T. Taconis, Titia Heijman, V. Sigurdsson, D. Adema, Elfi E. H. G. Brouwers, Petra J. Woestenberg, Menke J. de Smit, Johannes A. Bogaards, E. Pannekoek, E. van Koolwijk, I. Linde, P. Cornelissen, W. Vermeulen, C. van Bokhoven-Rombouts, Sylvia M. Bruisten, A. van Leeuwen, W. de Waal, R. Huisman, Marianne A B van der Sande, G. Aalfs, A. Botraby, Marcel Peeters, Hannelore M Götz, D. Abma, A.A. van der Eijk, R. Buist-Arkema, H. Korff, H. Bosch, C. de Haan, M. van Rooijen, H. van Buel-Bruins, S. Meijer, P. van Goor, E. Swaders, Fiona R. M. van der Klis, P. van Esch, M. Mattijssen, I. Polman, Birgit H B van Benthem, M. Dinnissen-van Poppel, J. Stam, John W. A. Rossen, Caroline M. A. Swanink, Rob Schuurman, T. Smits, J. Nelissen, C. Kampman, M. Peters, Willem J. G. Melchers, M. Pelgrim, C. Kerkhof, J. Velzing, Suzan Leussink, H. van Kruchten, D. Bukasa, P. van Rosmalen, Y. Poort, F. Neienhuijsen, M. Kersten, Anne-Marie Niekamp, R. Kleinspenkelink
Publikováno v:
Journal of Infection, 74(4), 393-400. W.B. Saunders Ltd
Journal of infection, 74(4), 393-400. W.B. Saunders Ltd
Journal of Infection, 74(4), 393-400. Elsevier Saunders
The Journal of Infection, 74(4), 393. W.B. Saunders Ltd
Woestenberg, P J, King, A J, van der Sande, M A B, Donken, R, Leussink, S, van der Klis, F R M, Hoebe, C J P A, Bogaards, J A, van Benthem, B H B, Medical Microbiological Laboratories & Public Health Services 2017, ' No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors ', Journal of Infection, vol. 74, no. 4, pp. 393-400 . https://doi.org/10.1016/j.jinf.2017.01.007
Journal of infection, 74(4), 393-400. W.B. Saunders Ltd
Journal of Infection, 74(4), 393-400. Elsevier Saunders
The Journal of Infection, 74(4), 393. W.B. Saunders Ltd
Woestenberg, P J, King, A J, van der Sande, M A B, Donken, R, Leussink, S, van der Klis, F R M, Hoebe, C J P A, Bogaards, J A, van Benthem, B H B, Medical Microbiological Laboratories & Public Health Services 2017, ' No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors ', Journal of Infection, vol. 74, no. 4, pp. 393-400 . https://doi.org/10.1016/j.jinf.2017.01.007
Objectives: Data from a vaccine trial and from post-vaccine surveillance in the United Kingdom have suggested that the bivalent HPV-16/18 vaccine offers cross-protection against HPV-6/11 and protection against anogenital warts (AGW). We studied the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf6537284f45bcb78b45a2a227cd66d
https://research.vumc.nl/en/publications/040b898e-99f2-4d28-8a25-7fe23bd62a42
https://research.vumc.nl/en/publications/040b898e-99f2-4d28-8a25-7fe23bd62a42
Autor:
Fiona R. M. van der Klis, Jeroen H. T. Tjhie, Birgit H B van Benthem, Petra J. Woestenberg, Hester E. de Melker, Jan E. A. M. van Bergen, Marianne A B van der Sande
Publikováno v:
BMC infectious diseases, 16(1). BioMed Central
BMC Infectious Diseases
BMC Infectious Diseases [E], 16. BioMed Central
BMC Infectious Diseases
BMC Infectious Diseases [E], 16. BioMed Central
Background Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sex